# Northland Nuclear Medicine, LLC – FDA Inspection, Jul 13, 2023

Source: https://www.keypedia.com/records/fda_inspections/northland-nuclear-medicine-llc/b625c27f-5639-4afc-a90f-39876f36f744
Source feed: FDA_Inspections

> FDA inspection 1210014 of Northland Nuclear Medicine, LLC, July 13, 2023. Classification: Official Action Indicated (OAI). 6 citations under 21 CFR part 212. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1210014
- Company Name: Northland Nuclear Medicine, LLC
- Inspection Date: 2023-07-13
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 6

## Related Documents

- [FDA Inspection 1092563 - 2019-06-07](https://www.keypedia.com/records/fda_inspections/northland-nuclear-medicine-llc/1d9a3582-f77c-4de9-b9c2-80c2cd2bbb27)

## Related Officers

- [Investigator](https://www.keypedia.com/people/lisa-l-flores/465a6807-55d7-4c3f-a415-c21ac4517bc9)

Company: https://www.keypedia.com/companies/northland-nuclear-medicine-llc/ea5b0f88-b6c0-4949-ad0d-aaa0d0e6fbd4

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
